Metropolitan Life Insurance Company (MetLife)’s Aeva Technologies AEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-461
Closed -$2.74K 2461
2023
Q1
$2.74K Sell
461
-902
-66% -$7.23K ﹤0.01% 2293
2022
Q4
$9.27K Sell
1,363
-8
-0.6% -$70 ﹤0.01% 2303
2022
Q3
$12.8K Buy
1,371
+527
+62% +$8.32K ﹤0.01% 2220
2022
Q2
$13.2K Sell
844
-645
-43% -$10.6K ﹤0.01% 2237
2022
Q1
$32.2K Sell
1,489
-4,420
-75% -$109K ﹤0.01% 1840
2021
Q4
$223K Buy
5,909
+1,510
+34% +$63.5K ﹤0.01% 1954
2021
Q3
$175K Buy
+4,399
New +$205K ﹤0.01% 2182

Other funds holding AEVA

Metropolitan Life Insurance Company (MetLife)'s AEVA Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Aeva Technologies (AEVA) in Q2 2023, closing a stake of 461 shares — an estimated $2.74K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AEVA in Q3 2021 and held it in 7 quarters. The position peaked at $223K in Q4 2021. 107 funds tracked by Wall St. Rank hold AEVA as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Aeva Technologies position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 461 Aeva Technologies shares in Q2 2023, an estimated $2.74K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Aeva Technologies in Q3 2021 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Aeva Technologies position peaked at $223K in Q4 2021.
  • 107 funds tracked by Wall St. Rank held Aeva Technologies as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.